Anna Hartwig, PhD
Lab Head
Exai Bio, Exai Bio
Pronouns: she/her
Current role: VP of Product and Technology Development at Exai Bio, focused on developing NGS-based RNA liquid biopsy cancer diagnostics. Prior roles include leading assay development for NGS-based diagnostic assays at Guardant Health and Toma Biosciences, and post doc research with Dr. Joan Steitz at Yale University focusing on ncRNA and transcription. PhD from the Karolinska Institute, Sweden, in experimental oncology.
My Presentations
We are still accepting POSTER abstracts. Once you have submitted an abstract, and it is approved, it will appear here a few days ahead of the meeting.
Topics of Interest
- RNA Mechanism
- RNA Technologies
- Sequence Exploration
